Biopsy and spinal fluid testing for newly diagnosed brain lymphoma
Part of Brain & nervous system, Cancer clinical trials.
This study uses brain biopsy and spinal fluid (lumbar puncture) tests to better diagnose and understand how well treatments may work for certain lymphomas in the brain. It may help doctors match the right therapy by studying what the disease looks like in the body and brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have newly diagnosed primary CNS lymphoma (a type of lymphoma mainly in the brain), or possibly a control condition related to high-risk CNS lymphoma
- Have available test results: scans (radiology), spinal fluid sample, and a brain tissue sample (biopsy) that is fresh or preserved
- Be able to safely have a brain biopsy and a lumbar puncture (spinal tap)
- Be able to receive lymphoma treatment by IV (chemo-immunotherapy) and/or whole-brain radiation if needed, with no major contraindications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how newly diagnosed primary central nervous system (brain) non-Hodgkin lymphoma responds to a specific type of radiation to the whole brain, and it also looks at changes in thinking, mood, and behavior. It may help doctors understand how this treatment affects day-to-day brain function.
This trial tests a new type of imaging scan to see if it can better detect and monitor brain lymphoma. It may help doctors tailor treatment by seeing how the cancer responds early on.
This trial tests a new method to improve the safety and accuracy of brain biopsies in people with a type of lymphoma that starts in the brain or spinal cord. It may help reduce complications and get more reliable results.
This study looks at genetic and molecular features of primary central nervous system diffuse large B-cell lymphoma to better understand the disease. It may help guide future treatments.
This study looks at how primary central nervous system (CNS) lymphoma can be identified and tracked using scans and molecular (tissue/biomarker) tests. It may help doctors better understand your disease and choose the best next steps.
This trial looks at the immune system and metabolism of people with primary central nervous system lymphoma (a type of brain cancer) to find differences that might help with future treatments. It does not test a new drug, but collects samples and medical information.
Hear when a new Primary CNS Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.